BNP test utilization for CHF in community hospital practice.
- 7 December 2002
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 328 (1) , 191-193
- https://doi.org/10.1016/s0009-8981(02)00374-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspneaJournal of the American College of Cardiology, 2002
- Role of brain natriuretic peptide in risk stratification of patients with congestive heart failureJournal of the American College of Cardiology, 2001
- The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunctionAmerican Heart Journal, 2001
- Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care settingJournal of the American College of Cardiology, 2001
- A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot studyJournal of the American College of Cardiology, 2001
- The Impact of Cardiac Natriuretic Peptide Determination on the Diagnosis and Management of Heart Failurecclm, 2001
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- The epidemiology of heart failureEuropean Heart Journal, 1997
- Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarctionJournal of the American College of Cardiology, 1996